| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.17 | 0.004 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |